Seeding of tumour in the needle track following percutaneous needle biopsy of liver neoplasms is rarely reported. We describe two such cases following the needle biopsy of an hepatocellular carcinoma and secondary colorectal carcinoma respectively. The risk of needle track recurrence of liver tumours should not be regarded as insignificant. The diagnosis of liver neoplasms may be achieved by non-invasive modalities, and their needle biopsy should be reserved for cases not amenable to surgical resection.
INTRODUCTION
Percutaneous needle biopsy is a commonly used technique in the diagnosis of malignant abdominal tumours, and it is widely held that the advantage of a high diagnostic yield outweighs the low complication rate. In particular, the recurrence of tumour in the biopsy track is said to be rare, with seeding frequencies of 0.005-0.009% quoted for large series of fine-needle abdominal biopsies1'2. However, as isolated cases of needle track seeding continue to be reported, there have It is generally accepted that percutaneous needle biopsy combined with radiological imaging is a safe and accurate means of confirming a tissue diagnosis in focal neoplastic liver disease 1,11. The apparent rarity of malignant implantation from abdominal neoplasms has been emphasised in large series of fine-needle aspiration biopsies1'2'12, by definition using a needle of 1 mm diameter (19 gauge) or less, although seeding of pancreatic [13] [14] [15] [16] and renal cell carcinoma 17 has been described following this technique. Conventional core-cutting needle biopsy is assumed to carry an increased risk of seeding, and this has been documented for carcinoma of the prostateTM, lung 19 and thyroid2. There is no direct evidence that core-cutting needles significantly increase the risk of tumour seeding, however, and it has been 5 demonstrated in animal models that it is possible to implant 10 -10 tumour cells in 21 the tracks of fine-needle aspiration biopsies Review of the cases where needle track seeding of liver tumours has occurred reveals no specific association with core-cutting needles (see Table 1 ).
The risk of seeding following needle biopsy of liver tumours can no longer be regarded as insignificant, and this case report provides further evidence that percutaneous needle biopsy track seeding of liver carcinomas may not be as rare as has been claimed. Its true incidence is probably under-reported in that many patients in whom a needle biopsy diagnosis of hepatic malignancy is obtained will succumb with terminal carcinomatosis before metastasis to the parietes becomes apparent, although there is no evidence that biopsy of liver tumour adversely affects survival.
Hepatic resection for hepatocellular carcinoma 22 and colorectal metastases 23 in I think it is very important to insist that apart from academic studies conducted within strict protocols, no investigation, especially an invasive one, be carried out unless it can be demonstrated that the result will affect subsequent management. In the case of a space occupying lesion in the liver, there are available a multitude of investigative procedures, as a result of which a fairly certain diagnosis, especially in relation to its benign or malignant nature, can be made. Once a lesion has been identified and there is a strong suspicion that it is malignant or if it is causing symptoms, then the question of surgical resection must be considered. Resection of lesions from otherwise normal livers in major centres is an acceptable procedure accompanied by a low morbidity and mortality. However this is not so if the
